Insights

Innovative Health Platform Sema4's advanced health intelligence platform, Centrellis®, leverages AI and machine learning to provide personalized health insights, positioning the company as a key partner for healthcare providers and insurers seeking data-driven solutions to improve patient outcomes.

Recent AI Expansion With the recent launch of their full-stack AI agent platform and recognition in Gartner reports, Sema4.ai demonstrates a strong commitment to enterprise AI solutions, opening up opportunities for organizations looking to incorporate autonomous AI tools for complex decision-making.

Growth Funding Opportunities Having secured over $30 million in funding to develop open-source AI, Sema4 is positioned for targeted investments to enhance AI capabilities, presenting potential avenues for collaboration and sales in AI-driven healthcare and enterprise markets.

Market Differentiation Unlike larger competitors, Sema4's focus on personalized, patient-centered health data provides a unique value proposition that can be attractive to health systems, biotech partners, and payers aiming for tailored, data-enhanced healthcare services.

Industry Collaboration Potential Given its focus on integrating multidimensional clinical and genomic data, Sema4 offers opportunities for partnerships with biotech, genomics, and healthcare organizations looking to leverage advanced analytics and AI for research and clinical applications.

Sema4 Tech Stack

Sema4 uses 6 technology products and services including Amazon Web Services, Bitly, Lever, and more. Explore Sema4's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Bitly
    Marketing
  • Lever
    Recruitment Marketing
  • Google
    Search Engines
  • Zoom
    Web Conferencing
  • Google Hangouts
    Web Conferencing

Media & News

Sema4's Email Address Formats

Sema4 uses at least 2 format(s):
Sema4 Email FormatsExamplePercentage
First.Last@sema4.comJohn.Doe@sema4.com
98%
First.Middle@sema4.comJohn.Michael@sema4.com
2%
First.Last@sema4genomics.comJohn.Doe@sema4genomics.com
98%
LastFirst@sema4genomics.comDoeJohn@sema4genomics.com
1%
LF@sema4genomics.comDJ@sema4genomics.com
1%

Frequently Asked Questions

Where is Sema4's headquarters located?

Minus sign iconPlus sign icon
Sema4's main headquarters is located at 333 Ludlow Street Stamford, Connecticut 06902 United States. The company has employees across 6 continents, including North AmericaEuropeAfrica.

What is Sema4's stock symbol?

Minus sign iconPlus sign icon
Sema4 is a publicly traded company; the company's stock symbol is SMFR.

How much revenue does Sema4 generate?

Minus sign iconPlus sign icon
As of June 2026, Sema4's annual revenue is estimated to be $12B.

What is Sema4's SIC code NAICS code?

Minus sign iconPlus sign icon
Sema4's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sema4 have currently?

Minus sign iconPlus sign icon
As of June 2026, Sema4 has approximately 142 employees across 6 continents, including North AmericaEuropeAfrica. Key team members include Cso: L. H.Cro, Chief Revenue Cycle Officer: T. S.Chief Operating Officer: J. M.. Explore Sema4's employee directory with LeadIQ.

What industry does Sema4 belong to?

Minus sign iconPlus sign icon
Sema4 operates in the Biotechnology Research industry.

What technology does Sema4 use?

Minus sign iconPlus sign icon
Sema4's tech stack includes Amazon Web ServicesBitlyLeverGoogleZoomGoogle Hangouts.

What is Sema4's email format?

Minus sign iconPlus sign icon
Sema4's email format typically follows the pattern of First.Last@sema4.com. Find more Sema4 email formats with LeadIQ.

When was Sema4 founded?

Minus sign iconPlus sign icon
Sema4 was founded in 2017.

Sema4

Biotechnology ResearchConnecticut, United States51-200 Employees

Sema4 is a biotechnology research company based in Stamford, Connecticut. It focuses on patient-centered health intelligence, applying artificial intelligence and machine learning to longitudinal clinical and genomic data to build dynamic models of health and individualized health trajectories. The company’s Centrellis health intelligence platform supports a more complete understanding of disease and wellness and informs science-driven solutions to pressing medical needs.

Operating at the intersection of biotechnology and data science, Sema4 aims to advance healthcare through data-driven insights while treating patients as partners and endorsing data sharing for the benefit of all. A notable recent development is the November 2024 announcement of the general availability of a full-stack AI agent platform from Sema4.ai, reflecting an expansion of its AI capabilities for enterprise work.

Section iconCompany Overview

Headquarters
333 Ludlow Street Stamford, Connecticut 06902 United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SMFR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $10B

    Sema4's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $10B

    Sema4's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.